Lakefront Biotherapeutics (LKFT) Prepaid Assets (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported Prepaid Assets of $4.8 million for Q1 2026, down 85.52% year-over-year from $32.9 million in Q1 2025, and down 41.47% quarter-over-quarter from $8.2 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Prepaid Assets (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of Prepaid Assets data on file, last reported at $4.8 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $4.8 million, down 85.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (down 85.52% YoY), and the FY2025 annual result was $8.2 million, up 7305.27% from the prior year.
- Prepaid Assets retreated to $4.8 million in Q1 2026 per LKFT's latest filing, from $8.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $32.9 million in Q1 2025 and troughed at $110065.3 in Q4 2024.
- A 5-year average of $14.5 million and a median of $13.2 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets slumped 86.14% in 2024, then jumped 7305.27% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $497880.7 in 2022, then surged by 59.48% to $794043.7 in 2023, then tumbled by 86.14% to $110065.3 in 2024, then jumped by 7305.27% to $8.2 million in 2025, then sank by 41.47% to $4.8 million in 2026.
- Business Quant data shows LKFT's Prepaid Assets at $4.8 million in Q1 2026, $8.2 million in Q4 2025, and $13.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.77 Mn |
| Dec 31, 2025 | 8.15 Mn |
| Sep 30, 2025 | 13.20 Mn |
| Jun 30, 2025 | 23.04 Mn |
| Mar 31, 2025 | 32.94 Mn |
| Dec 31, 2024 | 110,065.33 |
| Sep 30, 2024 | 29.63 Mn |
| Mar 31, 2024 | 17.07 Mn |
| Dec 31, 2023 | 794,043.65 |
| Sep 30, 2023 | 17.13 Mn |
| Mar 31, 2023 | 29.94 Mn |
| Dec 31, 2022 | 497,880.71 |
| Mar 31, 2022 | 11.68 Mn |
| Dec 31, 2021 | 231,082.13 |
| Jun 30, 2021 | 11.18 Mn |
| Dec 31, 2020 | 261,111.48 |
| Jun 30, 2020 | 11.37 Mn |
| Mar 31, 2020 | 9.61 Mn |
| Dec 31, 2019 | 323,211.20 |
| Sep 30, 2019 | 9.83 Mn |